Literature DB >> 30375541

An Unusual Cause of Oligoarthritis and Erythema Nodosum: Idiopathic Granulomatous Mastitis.

Seçil Vural1, Pelin Ertop1, Koray Ceyhan2, Hatice Şanli1.   

Abstract

Idiopathic granulomatous mastitis (IGM) is an unusual benign inflammatory disease of breast. Breast cancer mimics IGM both radiologically and clinically. However, IGM is a benign disease and awareness of such an entity prevents unnecessary surgical procedures. Although its etiology is unknown, it may be an autoimmune disease. There are few patients reported in the literature presenting with reactive arthritis and/or erythema nodosum accompanying IGM of breast. Granulomatous mastitis should be considered as a possible underlying cause of arthritis and erythema nodosum. In this article, we report this interesting association of IGM as an underlying cause of arthritis and generalized erythema nodosum in a 32-year-old female patient. Comprehensive examination for granulomatous mastitis showed no apparent underlying cause. Indomethacin was beneficial in treatment of arthritis and erythema nodosum. Resistant IGM was responsive to colchicine treatment. Clinical management and therapeutic approach have been discussed in detail.

Entities:  

Keywords:  Arthritis; erythema nodosum; idiopathic granulomatous

Year:  2017        PMID: 30375541      PMCID: PMC6190935          DOI: 10.5606/ArchRheumatol.2017.5952

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  19 in total

Review 1.  Idiopathic granulomatous lobular mastitis.

Authors:  Frederick A Pereira; Adarsh V Mudgil; Edgar S Macias; Karen Karsif
Journal:  Int J Dermatol       Date:  2012-02       Impact factor: 2.736

Review 2.  Methotrexate in the management of idiopathic granulomatous mastitis: review of 108 published cases and report of four cases.

Authors:  Sami Akbulut; Davut Yilmaz; Sule Bakir
Journal:  Breast J       Date:  2011-09-21       Impact factor: 2.431

3.  First report of idiopathic granulomatous mastitis treated with methotrexate monotherapy.

Authors:  Gabriela Schmajuk; Mark C Genovese
Journal:  J Rheumatol       Date:  2009-07       Impact factor: 4.666

4.  Granulomatous mastitis: a lesion clinically simulating carcinoma.

Authors:  E Kessler; Y Wolloch
Journal:  Am J Clin Pathol       Date:  1972-12       Impact factor: 2.493

5.  Management of idiopathic granulomatous mastitis with observation.

Authors:  Marcia E Bouton; Lakshmi Jayaram; Patrick J O'Neill; Chiu-Hsieh Hsu; Ian K Komenaka
Journal:  Am J Surg       Date:  2015-02-07       Impact factor: 2.565

6.  A case of granulomatous mastitis with erythema nodosum and arthritis.

Authors:  Mansour Salesi; Mansoor Karimifar; Fereshteh Salimi; Parvin Mahzouni
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

7.  Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study.

Authors:  A Néel; M Hello; A Cottereau; J Graveleau; P De Faucal; N Costedoat-Chalumeau; M Rondeau-Lutz; C Lavigne; L Chiche; E Hachulla; S Seiberras; J Cabane; N Tournemaine; M Hamidou
Journal:  QJM       Date:  2013-02-13

8.  Idiopathic granulomatous mastitis: a 25-year experience.

Authors:  Bilal Al-Khaffaf; Fiona Knox; Nigel J Bundred
Journal:  J Am Coll Surg       Date:  2007-10-29       Impact factor: 6.113

9.  Weber-Christian panniculitis: a review of 30 cases with this diagnosis.

Authors:  J W White; R K Winkelmann
Journal:  J Am Acad Dermatol       Date:  1998-07       Impact factor: 11.527

10.  Granulomatous mastitis, erythema nodosum, and oligoarthritis in a pregnant woman.

Authors:  Asiie Olfatbakhsh; Toktam Beheshtian; Gholamreza Esmaeeli Djavid
Journal:  Breast J       Date:  2008-10-14       Impact factor: 2.431

View more
  1 in total

Review 1.  Granulomatous mastitis, erythema nodosum and arthritis syndrome: case-based review.

Authors:  Konstantinos Parperis; Savvas Achilleos; Egli Costi; Michail Vardas
Journal:  Rheumatol Int       Date:  2021-03-01       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.